Efficacy and Safety of Biosimilar QL1207 vs. the Reference Aflibercept for Patients with Neovascular Age-Related Macular Degeneration: A Randomized Phase 3 Trial

被引：0

作者：

Bing Li

Ke Fan

Tonghe Zhang

Zhifeng Wu

Siming Zeng

Mingwei Zhao

Qian Ren

Dongping Zheng

Lifei Wang

Xiaoling Liu

Mei Han

Yanping Song

Jian Ye

Cheng Pei

Jinglin Yi

Xian Wang

Hui Peng

Hong Zhang

Zhanyu Zhou

Xiaoling Liang

Fangliang Yu

Miaoqin Wu

Chaopeng Li

Chunling Lei

Jilong Hao

Luosheng Tang

Huiping Yuan

Shanjun Cai

Qiuming Li

Jingxiang Zhong

Suyan Li

Lin Liu

Min Ke

Jing Wang

Hui Wang

Mengli Zhu

Zenghua Wang

Yang Yan

Feng Wang

Youxin Chen

机构：

[1] Peking Union Medical College Hospital,Ophthalmology Department

[2] Henan Provincial Eye Hospital,Ophthalmology Department

[3] Jinan Second People’s Hospital,Ophthalmology Department

[4] Wuxi Second People’s Hospital,Ophthalmology Department

[5] Guangxi Zhuang Autonomous Region People’s Hospital,Ophthalmology Department

[6] Peking University People’s Hospital,Ophthalmology Department

[7] Shijiazhuang People’s Hospital,Ophthalmology Department

[8] Shanxi Ophthalmic Hospital,Ophthalmology Department

[9] Hebei Eye Hospital,Ophthalmology Department

[10] Eye Hospital,Ophthalmology Department

[11] WMU Zhejiang Eye Hospital,Ophthalmology Department

[12] Tianjin Eye Hospital,Ophthalmology Department

[13] General Hospital of Central Theater Command,Ophthalmology Department

[14] Army Medical Center of PLA,Ophthalmology Department

[15] The First Affiliated Hospital of Xi’an Jiaotong University,Ophthalmology Department

[16] Affiliated Eye Hospital of Nanchang University,Ophthalmology Department

[17] The Affiliated Hospital of Guizhou Medical University,Ophthalmology Department

[18] The First Affiliated Hospital of Chongqing Medical University,Ophthalmology Department

[19] The First Affiliated Hospital of Harbin Medical University,Ophthalmology Department

[20] Qingdao Municipal Hospital,Ophthalmology Department

[21] Zhongshan Ophthalmic Center,Ophthalmology Department

[22] Sun Yat-Sen University,Ophthalmology Department

[23] The First Hospital of Nanchang,Ophthalmology Department

[24] Zhejiang Provincial People’s Hospital,Ophthalmology Department

[25] Huai’an First People’s Hospital,Ophthalmology Department

[26] Xi’an People’s Hospital,Ophthalmology Department

[27] First Hospital of Jilin University,Ophthalmology Department

[28] The Second Xiangya Hospital of Center South University,Ophthalmology Department

[29] The Second Affiliated Hospital of Harbin Medical University,Ophthalmology Department

[30] Affiliated Hospital of Zunyi Medical University,Ophthalmology Department

[31] The First Affiliated Hospital of Zhengzhou University,Ophthalmology Department

[32] The First Affiliated Hospital of Jinan University,Ophthalmology Department

[33] Xuzhou First People’s Hospital,Ophthalmology Department

[34] Renji Hospital Affiliated to Shanghai Jiaotong University,Clinical Research Center

[35] Wuhan University Zhongnan Hospital,Ophthalmology Department

[36] Qilu Pharmaceutical Co.,undefined

[37] Ltd.,undefined

[38] The Second Affiliated Hospital of Xi’an Jiaotong University,undefined

来源：

Ophthalmology and Therapy | 2024年 / 13卷

关键词：

Neovascular age-related macular degeneration; QL1207; Aflibercept; Biosimilar;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：353 / 366

页数：13

共 50 条

[31] Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept
Kim, Min Chul
Kim, Jae Hui
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2023, 64 (08): : 700 - 708
[32] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
Min, Ji Sang
Jung, Hyun Chul
Suh, Ji Young
Kwon, Yoon Hyung
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
[33] Effect of intravitreal aflibercept (Eylea®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration
Gok, Mustafa
Kapti, Hasan Burhanettin
INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (02) : 713 - 719
[34] Comparison of intraocular pressure changes in Japanese patients with neovascular age-related macular degeneration treated with aflibercept or faricimab
Honjo, Junichiro
Mukai, Ryo
Itagaki, Kanako
Tanaka, Keiichiro
Norikawa, Koki
Kato, Yutaka
Kasai, Akihito
Sugano, Yukinori
Sekiryu, Tetsuju
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2025, : 230 - 235
[35] Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration The STAIRWAY Phase 2 Randomized Clinical Trial
Khanani, Arshad M.
Patel, Sunil S.
Ferrone, Philip J.
Osborne, Aaron
Sahni, Jayashree
Grzeschik, Susanna
Basu, Karen
Ehrlich, Jason S.
Haskova, Zdenka
Dugel, Pravin U.
JAMA OPHTHALMOLOGY, 2020, 138 (09) : 964 - 972
[36] Blood coagulation parameters after intravitreal injection of aflibercept in patients with neovascular age-related macular degeneration
Hasan Altinkaynak
Meltem Ece Kars
Piraye Zeynep Kurkcuoglu
Nagihan Ugurlu
International Ophthalmology, 2018, 38 : 2397 - 2402
[37] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
Itagaki, Kanako
Sekiryu, Tetsuju
Kasai, Akihito
Sugano, Yukinori
Ogasawara, Masashi
Saito, Masaaki
BMC OPHTHALMOLOGY, 2020, 20 (01)
[38] Blood coagulation parameters after intravitreal injection of aflibercept in patients with neovascular age-related macular degeneration
Altinkaynak, Hasan
Kars, Meltem Ece
Kurkcuoglu, Piraye Zeynep
Ugurlu, Nagihan
INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (06) : 2397 - 2402
[39] Three-year outcome of aflibercept treatment for Japanese patients with neovascular age-related macular degeneration
Kanako Itagaki
Tetsuju Sekiryu
Akihito Kasai
Yukinori Sugano
Masashi Ogasawara
Masaaki Saito
BMC Ophthalmology, 20
[40] Densitometric analysis of cornea in patients with neovascular age-related macular degeneration after intravitreal aflibercept loading dose
Ucgul Atilgan, Cemile
Kosekahya, Pinar
Ozkoyuncu Kocabas, Dilara
Koc, Mustafa
Sakir Goker, Yasin
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2020, 12

← 1 2 3 4 5 →